Genistein as a Potential Anticancer Agent against Ovarian Cancer

Jung-Yun Lee；Hee Seung Kim；Yong-Sang Song

Genistein ； Isoflavone ； Ovarian cancer

Journal of Traditional and Complementary Medicine

2卷2期（2012 / 04 / 01）

96 - 104

英文

Genistein is known as the major component of isoflavone, which is present in high-soy diets. Genistein has received much attention because of its chemopreventive and therapeutic effects on various types of cancers. Numerous studies have shown that genistein has antineoplastic effects against ovarian cancer. Several epidemiological studies have shown that women who have high consumption of isoflavones have a relatively low incidence of ovarian cancer. Genistein inhibits ovarian carcinogenesis by pleiotropic mechanisms. A higher affinity to estrogen receptor β is one probable explanation for its ability to reduce the risk of ovarian cancer. Genistein also targets multiple cellular signal transduction pathways associated with cell cycle regulation and apoptosis. In addition, genistein has been suggested to have antiangiogenic and antioxidant activities. Herein, we summarize recent results from epidemiological and experimental studies to identify the role of genistein in ovarian cancer. Further studies are needed to achieve conclusive results and determine the clinical applications of genistein.

1. Adlercreutz, H.,Markkanen, H.,Watanabe, S.(1993).Plasma concentrations of phyto-oestrogens in Japanese men.Lancet,342,1209-1210.
2. Ahmed, A.A.,Goldsmith, J.,Fokt, I.,Le, X.F.,Krzysko, K.A.,Lesyng, B.,Bast, R.C., Jr.,Priebe, W.(2011).A genistein derivative, ITB-301, induces microtubule depolymerization and mitotic arrest in multidrug-resistant ovarian cancer.Cancer Chemotherapy and Pharmacology,68,1033-1044.
3. Akiyama, T.,Ishida, J.,Nakagawa, S.,Ogawara, H.,Watanabe, S.,Itoh, N.,Shibuya, M.,Fukami, Y.(1987).Genistein, a specific inhibitor of tyrosine-specific protein kinases.Journal of Biological Chemistry,262,5592-5595.
4. Allred, C.D.,Allred, K.F.,Ju, Y.H.,Virant, S.M.,Helferich, W.G.(2001).Soy diets containing varying amounts of genistein stimulate growth of estrogen-dependent (MCF-7) tumors in a dose-dependent manner.Cancer Research,61,5045-5050.
5. Ames, B.N.,Gold, L.S.,Willett, W.C.(1995).The causes and prevention of cancer.Proceedings of the National Academy of Sciences of the United States of America,92,5258-5265.
6. Andres, S.,Abraham, K.,Appel, K.E.,Lampen, A.(2011).Risks and benefits of dietary isoflavones for cancer.Critical Reviews in Toxicology,41,463-506.
7. Bandera, E.V.,King, M.,Chandran, U.,Paddock, L.E.,Rodriguez-Rodriguez, L.,Olson, S.H.(2011).Phytoestrogen consumption from foods and supplements and epithelial ovarian cancer risk: a population-based case control study.BMC Women’s Health,11,40.
8. Banerjee, S.,Li, Y.,Wang, Z.,Sarkar, F.H.(2008).Multi-targeted therapy of cancer by genistein.Cancer Letters,269,226-242.
9. Brandenberger, A.W.,Tee, M.K.,Jaffe, R.B.(1998).Estrogen receptor alpha (ER-alpha) and beta (ER-beta) mRNAs in normal ovary, ovarian serous cystadenocarcinoma and ovarian cancer cell lines: down-regulation of ER-beta in neoplastic tissues.Journal of Clinical Endocrinology and Metabolism,83,1025-1028.
10. Brunet, A.,Bonni, A.,Zigmond, M.J.,Lin, M.Z.,Juo, P.,Hu, L.S.,Anderson, M.J.,Arden, K.C.,Blenis, J.,Greenberg, M.E.(1999).Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.Cell,96,857-868.
11. Cardone, M.H.,Roy, N.,Stennicke, H.R.,Salvesen, G.S.,Franke, T.F.,Stanbridge, E.,Frisch, S.,Reed, J.C.(1998).Regulation of cell death protease caspase-9 by phosphorylation.Science,282,1318-1321.
12. Carmeliet, P.,Jain, R.K.(2000).Angiogenesis in cancer and other diseases.Nature,407,249-257.
13. Chang, E.T.,Lee, V.S.,Canchola, A.J.,Clarke, C.A.,Purdie, D.M.,Reynolds, P.,Anton-Culver, H.,Bernstein, L.,Deapen, D.,Peel, D.,Pinder, R.,Ross, R.K.,Stram, D.O.,West, D.W.,Wright, W.,Ziogas, A.,Horn-Ross, P.L.(2007).Diet and risk of ovarian cancer in the California Teachers Study cohort.American Journal of Epidemiology,165,802-813.
14. Chen, X.,Anderson, J.J.(2001).Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway.Nutrition and Cancer,41,165-171.
15. Choi, E.J.,Kim, T.,Lee, M.S.(2007).Pro-apoptotic effect and cytotoxicity of genistein and genistin in human ovarian cancer SK-OV-3 cells.Life Science,80,1403-1408.
16. Chu, S.,Mamers, P.,Burger, H.G.,Fuller, P.J.(2000).Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors.Journal of Clinical Endocrinology and Metabolism,85,1200-1205.
17. Couse, J.F.,Lindzey, J.,Grandien, K.,Gustafsson, J.A.,Korach, K.S.(1997).Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse.Endocrinology,138,4613-4621.
18. Davis, J.N.,Kucuk, O.,Djuric, Z.,Sarkar, F.H.(2001).Soy isoflavone supplementation in healthy men prevents NF-kappa B activation by TNF-alpha in blood lymphocytes.Free Radical Biology and Medicine,30,1293-1302.
19. De Wilde, A.,Maria Rassi, C.,Cournot, G.,Colin, C.,Lacroix, H.C.,Chaumaz, G.,Coxam, V.,Bennetau-Pelissero, C.,Pointillart, A.,Lieberherr, M.(2007).Dietary isoflavones act on bone marrow osteoprogenitor cells and stimulate ovary development before influencing bone mass in pre-pubertal piglets.Journal of Physiological Sciences,212,51-59.
20. Diel, P.,Hertrampf, T.,Seibel, J.,Laudenbach-Leschowsky, U.,Kolba, S.,Vollmer, G.(2006).Combinatorial effects of the phytoestrogen genistein and of estradiol in uterus and liver of female Wistar rats.Journal of Steroid Biochemistry and Molecular Biology,102,60-70.
21. Dorward, A.M.,Shultz, K.L.,Beamer, W.G.(2007).LH analog and dietary isoflavones support ovarian granulosa cell tumor development in a spontaneous mouse model.Endocrine-Related Cancer,14,369-379.
22. Dreher, D.,Junod, A.F.(1996).Role of oxygen free radicals in cancer development.European Journal of Cancer Prevention,32,30-38.
23. Elstrom, R.L.,Bauer, D.E.,Buzzai, M.,Karnauskas, R.,Harris, M.H.,Plas, D.R.,Zhuang, H.,Cinalli, R.M.,Alavi, A.,Rudin, C.M.,Thompson, C.B.(2004).Akt stimulates aerobic glycolysis in cancer cells.Cancer Research,64,3892-3899.
24. Fathalla, M.F.(1971).Incessant ovulation--a factor in ovarian neoplasia?.Lancet,2,163.
25. Fotsis, T.,Pepper, M.,Adlercreutz, H.,Hase, T.,Montesano, R.,Schweigerer, L.(1995).Genistein, a dietary ingested isoflavonoid, inhibits cell proliferation and in vitro angiogenesis.Journal of Nutrition,125,790-797.
26. Gercel-Taylor, C.,Feitelson, A.K.,Taylor, D.D.(2004).Inhibitory effect of genistein and daidzein on ovarian cancer cell growth.Anticancer Research,24,795-800.
27. Gossner, G.,Choi, M.,Tan, L.,Fogoros, S.,Griffith, K.A.,Kuenker, M.,Liu, J.R.(2007).Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells.Gynecologic Oncology,105,23-30.
28. Harris, D.M.,Besselink, E.,Henning, S.M.,Go, V.L.,Heber, D.(2005).Phytoestrogens induce differential estrogen receptor alpha- or Beta-mediated responses in transfected breast cancer cells.Experimental Biology and Medicine,230,558-568.
29. Hedelin, M.,Lof, M.,Andersson, T.M.,Adlercreutz, H.,Weiderpass, E.(2011).Dietary phytoestrogens and the risk of ovarian cancer in the women's lifestyle and health cohort study.Cancer Epidemiology, Biomarkers & Prevention,20,308-317.
30. Hernandez-Montes, E.,Pollard, S.E.,Vauzour, D.,Jofre-Montseny, L.,Rota, C.,Rimbach, G.,Weinberg, P.D.,Spencer, J.P.(2006).Activation of glutathione peroxidase via Nrf1 mediates genistein's protection against oxidative endothelial cell injury.Biochemical and Biophysical Research Communications,346,851-859.
31. Kasiske, B.L.,O'donnell, M.P.,Lee, H.,Kim, Y.,Keane, W.F.(1991).Impact of dietary fatty acid supplementation on renal injury in obese Zucker rats.Kidney International,39,1125-1134.
32. Kim, M.K.,Kim, K.,Han, J.Y.,Lim, J.M.,Song, Y.S.(2011).Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer.Genes and Nutrition,6,109-115.
33. Kuiper, G.G.,Lemmen, J.G.,Carlsson, B.,Corton, J.C.,Safe, S.H.,Van Der Saag, P.T.,Van Der Burg, B.,Gustafsson, J.A.(1998).Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta.Endocrinology,139,4252-4263.
34. Kyle, E.,Neckers, L.,Takimoto, C.,Curt, G.,Bergan, R.(1997).Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity.Molecular Pharmacology,51,193-200.
35. Lee, H.P.,Gourley, L.,Duffy, S.W.,Esteve, J.,Lee, J.,Day, N.E.(1991).Dietary effects on breast-cancer risk in Singapore.Lancet,337,1197-1200.
36. Lee, M.M.,Gomez, S.L.,Chang, J.S.,Wey, M.,Wang, R.T.,Hsing, A.W.(2003).Soy and isoflavone consumption in relation to prostate cancer risk in China.Cancer Epidemiology, Biomarkers and Prevention,12,665-668.
37. Li, Y.,Bhuiyan, M.,Sarkar, F.H.(1999).Induction of apoptosis and inhibition of c-erbB-2 in MDA-MB-435 cells by genistein.International Journal of Oncology,15,525-533.
38. Li, Y.,Sarkar, F.H.(2002).Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway.Clinical Cancer Research,8,2369-2377.
39. Lian, Z.,Niwa, K.,Tagami, K.,Hashimoto, M.,Gao, J.,Yokoyama, Y.,Mori, H.,Tamaya, T.(2001).Preventive effects of isoflavones, genistein and daidzein, on estradiol-17beta-related endometrial carcinogenesis in mice.Japanese Journal of Cancer Research,92,726-734.
40. Luo, H.,Jiang, B.H.,King, S.M.,Chen, Y.C.(2008).Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids.Nutrition and Cancer,60,800-809.
41. Magee, P.J.,Rowland, I.R.(2004).Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.British Journal of Nutrition,91,513-531.
42. Mosselman, S.,Polman, J.,Dijkema, R.(1996).ER beta: identification and characterization of a novel human estrogen receptor.FEBS Letters,392,49-53.
43. Myung, S.K.,Ju, W.,Choi, H.J.,Kim, S.C.(2009).Soy intake and risk of endocrine-related gynaecological cancer: a meta-analysis.British Journal of Obstetrics and Gynaecology,116,1697-1705.
44. Ness, R.B.,Cottreau, C.(1999).Possible role of ovarian epithelial inflammation in ovarian cancer.Journal of the National Cancer Institute,91,1459-1467.
45. Oesterreich, S.,Zhang, P.,Guler, R.L.,Sun, X.,Curran, E.M.,Welshons, W.V.,Osborne, C.K.,Lee, A.V.(2001).Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.Cancer Research,61,5771-5777.
46. Ouyang, G.,Yao, L.,Ruan, K.,Song, G.,Mao, Y.,Bao, S.(2009).Genistein induces G2/M cell cycle arrest and apoptosis of human ovarian cancer cells via activation of DNA damage checkpoint pathways.Cell Biology International,33,1237-1244.
47. Ozes, O.N.,Mayo, L.D.,Gustin, J.A.,Pfeffer, S.R.,Pfeffer, L.M.,Donner, D.B.(1999).NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase.Nature,401,82-85.
48. Parkin, D.M.,Pisani, P.,Ferlay, J.(1999).Global cancer statistics.CA: A Cancer Journal of Clinicians,49,31+33-64.
49. Peeters, P.H.,Keinan-Boker, L.,Van Der Schouw, Y.T.,Grobbee, D.E.(2003).Phytoestrogens and breast cancer risk. Review of the epidemiological evidence.Breast Cancer Research and Treatment,77,171-183.
50. Pike, A.C.,Brzozowski, A.M.,Hubbard, R.E.,Bonn, T.,Thorsell, A.G.,Engstrom, O.,Ljunggren, J.,Gustafsson, J.A.,Carlquist, M.(1999).Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist.EMBO Journal,18,4608-4618.
51. Rimoldi, G.,Christoffel, J.,Seidlova-Wuttke, D.,Jarry, H.,Wuttke, W.(2007).Effects of chronic genistein treatment in mammary gland, uterus, and vagina.Environmental Health Perspectives,115,62-68.
52. Romashkova, J.A.,Makarov, S.S.(1999).NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling.Nature,401,86-90.
53. Rossi, M.,Negri, E.,Lagiou, P.,Talamini, R.,Dal Maso, L.,Montella, M.,Franceschi, S.,La Vecchia, C.(2008).Flavonoids and ovarian cancer risk: A case-control study in Italy.International Journal of Cancer,123,895-898.
54. Rucinska, A.,Kirko, S.,Gabryelak, T.(2007).Effect of the phytoestrogen, genistein-8-C-glucoside, on Chinese hamster ovary cells in vitro.Cell Biology International,31,1371-1378.
55. Ruiz-Larrea, M.B.,Mohan, A.R.,Paganga, G.,Miller, N.J.,Bolwell, G.P.,Rice-Evans, C.A.(1997).Antioxidant activity of phytoestrogenic isoflavones.Free Radical Research,26,63-70.
56. Sakauchi, F.,Khan, M.M.,Mori, M.,Kubo, T.,Fujino, Y.,Suzuki, S.,Tokudome, S.,Tamakoshi, A.(2007).Dietary habits and risk of ovarian cancer death in a large-scale cohort study (JACC study) in Japan.Nutrtion and Cancer,57,138-145.
57. Sarkar, F.H.,Li, Y.(2002).Mechanisms of cancer chemoprevention by soy isoflavone genistein.Cancer Metastasis Reviews,21,265-280.
58. Semenza, G.L.,Artemov, D.,Bedi, A.,Bhujwalla, Z.,Chiles, K.,Feldser, D.,Laughner, E.,Ravi, R.,Simons, J.,Taghavi, P.,Zhong, H.(2001).'The metabolism of tumours': 70 years later.Novartis Foundation Symposium,240,251-260.
59. Seo, H.S.,Denardo, D.G.,Jacquot, Y.,Laios, I.,Vidal, D.S.,Zambrana, C.R.,Leclercq, G.,Brown, P.H.(2006).Stimulatory effect of genistein and apigenin on the growth of breast cancer cells correlates with their ability to activate ER alpha.Breast Cancer Research and Treatment,99,121-134.
60. Solomon, L.A.,Ali, S.,Banerjee, S.,Munkarah, A.R.,Morris, R.T.,Sarkar, F.H.(2008).Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB.Journal of Ovarian Research,1,9.
61. Spinozzi, F.,Pagliacci, M.C.,Migliorati, G.,Moraca, R.,Grignani, F.,Riccardi, C.,Nicoletti, I.(1994).The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells.Leukemia Research,18,431-439.
62. Stadel, B.V.(1975).Letter: The etiology and prevention of ovarian cancer.American Journal of Obstetrics and Gynecology,123,772-774.
63. Strom, A.,Hartman, J.,Foster, J.S.,Kietz, S.,Wimalasena, J.,Gustafsson, J.A.(2004).Estrogen receptor beta inhibits 17beta-estradiol-stimulated proliferation of the breast cancer cell line T47D.Proceedings of the National Academy of Sciences of the United States of America,101,1566-1571.
64. Tanaka, T.,Kohno, H.,Tanino, M.,Yanaida, Y.(2002).Inhibitory effects of estrogenic compounds, 4-nonylphenol and genistein, on 7,12-dimethylbenz[a]anthracene-induced ovarian carcinogenesis in rats.Ecotoxicology and Environmental Safety,52,38-45.
65. Taylor, C.K.,Levy, R.M.,Elliott, J.C.,Burnett, B.P.(2009).The effect of genistein aglycone on cancer and cancer risk: a review of in vitro, preclinical, and clinical studies.Nutrition Reviews,67,398-415.
66. Treeck, O.,Pfeiler, G.,Mitter, D.,Lattrich, C.,Piendl, G.,Ortmann, O.(2007).Estrogen receptor {beta}1 exerts antitumoral effects on SK-OV-3 ovarian cancer cells.Journal of Endocrinology,193,421-433.
67. Trock, B.J.,Hilakivi-Clarke, L.,Clarke, R.(2006).Meta-analysis of soy intake and breast cancer risk.Journal of National Cancer Institute,98,459-471.
68. Van Antwerp, D.J.,Martin, S.J.,Kafri, T.,Green, D.R.,Verma, I.M.(1996).Suppression of TNF-alpha-induced apoptosis by NF-kappaB.Science,274,787-789.
69. Weber, G.(1977).Enzymology of cancer cells (first of two parts).New England Journal of Medicine,296,486-492.
70. Wu, M.,Lee, H.,Bellas, R.E.,Schauer, S.L.,Arsura, M.,Katz, D.,Fitzgerald, M.J.,Rothstein, T.L.,Sherr, D.H.,Sonenshein, G.E.(1996).Inhibition of NF-kappaB/Rel induces apoptosis of murine B cells.EMBO Journal,15,4682-4690.
71. Zhang, M.,Xie, X.,Lee, A.H.,Binns, C.W.(2004).Soy and isoflavone intake are associated with reduced risk of ovarian cancer in southeast china.Nutrition and Cancer,49,125-130.